JS-SEZ Emerges: Top Singapore Stocks Making Waves
Generado por agente de IAWesley Park
viernes, 10 de enero de 2025, 5:13 am ET1 min de lectura
AIYY--

The JS-SEZ (Joint Stock-SEZ) growth in Singapore is gaining momentum, with several sectors and industries driving the market's expansion. As an investor, it's crucial to stay informed about the top-performing stocks in this dynamic market. In this article, we'll explore the key sectors and industries driving the JS-SEZ growth and highlight three stocks with explosive growth potential.

1. iFAST Corporation Limited (SGX: AIY)
iFAST is a fintech company that hosts a platform for buying and selling unit trusts, equities, and bonds. Despite facing challenges in 2022, iFAST is confident of achieving high growth in revenue and profitability from 2023 till 2025. The group's ePension division is expected to start contributing materially, and its new digital bank in the UK is actively onboarding new originating counterparties and opening new payment corridors. iFAST has kept its total 2022 dividend constant at S$0.048, despite a significant drop in earnings per share.
2. Raffles Medical Group Ltd (SGX: BSL)
Raffles Medical Group is an integrated healthcare player offering health screening, specialist care, and dental and traditional Chinese medicine services. The group's network comprises three hospitals and more than 100 multi-disciplinary clinics. With the relaxation of COVID-19 containment measures in China, RMG expects more locals and expatriates to seek treatment at its hospitals in Chongqing and Shanghai. The group's business in Singapore is also expected to benefit from the return of local and foreign patients. RMG's long-term growth prospects are further boosted by the opening of an in-vitro fertilisation and assisted reproductive therapy centre in Le Cheng, Hainan, China, in the second quarter of 2023.
3. Sembcorp Industries Ltd (SGX: U96)
Sembcorp Industries is a global energy and urban development group with operations in Singapore, India, and the Middle East. The group's long-term power purchase agreement (PPA) with Micron (NASDAQ: MU) will add to earnings for 2023. The award of the first greenfield renewables project in the Middle East will also contribute to earnings growth in the long term. Sembcorp's gross renewables capacity has reached 9.8 GW, nearing its 2025 target of 10 GW, which will drive earnings growth. The group's balanced energy portfolio and project portfolio spanning 12,000 hectares across Asia position it well for long-term growth and expansion.
In conclusion, the JS-SEZ growth in Singapore is driven by several key sectors and industries, offering investors unique opportunities for stable growth and diversification. By focusing on top-performing stocks like iFAST Corporation Limited, Raffles Medical Group Ltd, and Sembcorp Industries Ltd, investors can capitalize on the market's growth potential while generating passive income through dividends. Stay informed about these and other promising stocks to make the most of the JS-SEZ growth in Singapore.
KSPI--
SG--

The JS-SEZ (Joint Stock-SEZ) growth in Singapore is gaining momentum, with several sectors and industries driving the market's expansion. As an investor, it's crucial to stay informed about the top-performing stocks in this dynamic market. In this article, we'll explore the key sectors and industries driving the JS-SEZ growth and highlight three stocks with explosive growth potential.

1. iFAST Corporation Limited (SGX: AIY)
iFAST is a fintech company that hosts a platform for buying and selling unit trusts, equities, and bonds. Despite facing challenges in 2022, iFAST is confident of achieving high growth in revenue and profitability from 2023 till 2025. The group's ePension division is expected to start contributing materially, and its new digital bank in the UK is actively onboarding new originating counterparties and opening new payment corridors. iFAST has kept its total 2022 dividend constant at S$0.048, despite a significant drop in earnings per share.
2. Raffles Medical Group Ltd (SGX: BSL)
Raffles Medical Group is an integrated healthcare player offering health screening, specialist care, and dental and traditional Chinese medicine services. The group's network comprises three hospitals and more than 100 multi-disciplinary clinics. With the relaxation of COVID-19 containment measures in China, RMG expects more locals and expatriates to seek treatment at its hospitals in Chongqing and Shanghai. The group's business in Singapore is also expected to benefit from the return of local and foreign patients. RMG's long-term growth prospects are further boosted by the opening of an in-vitro fertilisation and assisted reproductive therapy centre in Le Cheng, Hainan, China, in the second quarter of 2023.
3. Sembcorp Industries Ltd (SGX: U96)
Sembcorp Industries is a global energy and urban development group with operations in Singapore, India, and the Middle East. The group's long-term power purchase agreement (PPA) with Micron (NASDAQ: MU) will add to earnings for 2023. The award of the first greenfield renewables project in the Middle East will also contribute to earnings growth in the long term. Sembcorp's gross renewables capacity has reached 9.8 GW, nearing its 2025 target of 10 GW, which will drive earnings growth. The group's balanced energy portfolio and project portfolio spanning 12,000 hectares across Asia position it well for long-term growth and expansion.
In conclusion, the JS-SEZ growth in Singapore is driven by several key sectors and industries, offering investors unique opportunities for stable growth and diversification. By focusing on top-performing stocks like iFAST Corporation Limited, Raffles Medical Group Ltd, and Sembcorp Industries Ltd, investors can capitalize on the market's growth potential while generating passive income through dividends. Stay informed about these and other promising stocks to make the most of the JS-SEZ growth in Singapore.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios